Ansell Financial Statements From 2010 to 2024
ANSLF Stock | USD 20.80 0.20 0.95% |
Check Ansell financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Ansell's main balance sheet or income statement drivers, such as , as well as many indicators such as . Ansell financial statements analysis is a perfect complement when working with Ansell Valuation or Volatility modules.
Ansell |
Ansell Limited Company Current Valuation Analysis
Ansell's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Ansell Current Valuation | 2.74 B |
Most of Ansell's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Ansell Limited is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition |
In accordance with the recently published financial statements, Ansell Limited has a Current Valuation of 2.74 B. This is 80.95% lower than that of the Healthcare sector and 70.08% lower than that of the Medical Instruments & Supplies industry. The current valuation for all United States stocks is 83.54% higher than that of the company.
Ansell Limited Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Ansell's current stock value. Our valuation model uses many indicators to compare Ansell value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Ansell competition to find correlations between indicators driving Ansell's intrinsic value. More Info.Ansell Limited is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.59 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Ansell Limited is roughly 1.69 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Ansell's earnings, one of the primary drivers of an investment's value.About Ansell Financial Statements
Ansell stakeholders use historical fundamental indicators, such as Ansell's revenue or net income, to determine how well the company is positioned to perform in the future. Although Ansell investors may analyze each financial statement separately, they are all interrelated. For example, changes in Ansell's assets and liabilities are reflected in the revenues and expenses on Ansell's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Ansell Limited. Please read more on our technical analysis and fundamental analysis pages.
Ansell Limited designs, develops, and manufactures protection solutions in the Asia Pacific, Europe, the Middle East, Africa, Latin America, the Caribbean, and North America. Ansell Limited was founded in 1893 and is based in Richmond, Australia. Ansell operates under Medical Instruments Supplies classification in the United States and is traded on OTC Exchange. It employs 14000 people.
Currently Active Assets on Macroaxis
Other Information on Investing in Ansell Pink Sheet
Ansell financial ratios help investors to determine whether Ansell Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Ansell with respect to the benefits of owning Ansell security.